International Journal of Nanomedicine · 2019 · 88 citations · 24 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryNanoparticle Drug DeliveryNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle CharacterizationNanoparticle FormulationsRheumatoid ArthritisCombination Drug LoadingNanoparticle Drug DistributionNanoparticle PharmacologyNanoparticle Toxicity ReductionNanoparticle-mediated Bioavailability EnhancementNanoparticlesRheumatoid Arthritis TherapyTraditional Chinese Medicine
BACKGROUND: Prednisolone (PD) is extremely effective for treating rheumatoid arthritis (RA). However, it distributes nonspecifically throughout the body and its use is associated with serious side effects, which promoted us to compound it into a phytomedicine for greater efficacy and safety. METHODS: We combined PD with curcumin (CU), an effective monomer from traditional Chinese medicine, and human serum albumin (HSA) in a nanoparticulate system (N-PD/CU) to compensate for the poor bioavailability of PD and CU. N-PD/CU was prepared by high-pressure homogenization, and its characteristics were evaluated in vitro. Next, we investigated its toxicity and mechanism of anti-inflammatory to macrophages. Finally, its pharmacokinetics, biodistribution and therapeutic efficacy were assessed in rats with adjuvant-induced arthritis (AIA). RESULTS: N-PD/CU showed a narrow size distribution around 150.4 ± 2.4 nm, a polydispersity index of 0.22 ± 0.02 and drug loading efficiency (DLE) of 88.75 ± 1.82% for PD and 85.79 ± 1.43% for CU. N-PD/CU showed sustained release of both drugs in vitro. N-PD/CU had no toxicity to macrophages in vitro on concentrations between 0.1 and 1.2 μmol/mL. In activated macrophages, N-PD decreased levels of pro-inflammatory cytokines, while N-CU increased levels of anti-inflammatory IL-10, and N-PD/CU exhibited best therapeutic effect in vitro, suggesting co-delivery of PD and CU may synergistically control the course of RA. In AIA rats, N-PD/CU accumulated in inflamed joints through the effect of extravasation through leaky vasculature and subsequent inflammatory cell-mediated sequestration (ELVIS effect) in inflammatory lesion and showed higher therapeutic efficacy than single-loaded nanoparticles, either free drug on its own, or a simple mixture of the two drugs. CONCLUSION: This codelivery system based on HSA is a promising platform for combination chemotherapy in RA.
24
María Letizia Manca, Ines Castangia, Marco Zaru et al. · Biomaterials · 2015 · 229 citations · Full text
Veterinary Medicine, Dermatology, Molecular Pharmaceutics +15
Curcumin loaded solid lipid nanoparticles ameliorate adjuvant‐induced arthritis in rats
Rajesh Arora, Anurag Kuhad, Indu Pal Kaur et al. · European Journal of Pain · 2014 · 161 citations
Medicine, Immunology, Pharmacology +17